File(s) not publicly available
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
Version 2 2024-06-06, 07:11
Version 1 2023-02-09, 03:51
journal contribution
posted on 2024-06-06, 07:11 authored by MVM Similon, C Paasche, F Krol, B Lerer, GM Goodwin, Michael BerkMichael Berk, A Meyer-Lindenberg, TA Ketter, LN Yatham, JF Goldberg, GS Malhi, R El-Mallakh, RW Licht, AH Young, F Kapczinski, M Swartz, M Hagin, C Torrent, A Serretti, A Yildiz, A Martínez-Arán, S Strejilevich, J Rybakowski, G Sani, H Grunze, G Vázquez, AG Pinto, JM Azorin, W Nolen, O Sentissi, C López-Jaramillo, BN Frey, A Nierenberg, G Parker, DJ Bond, A Cohen, A Tortorella, G Perugi, E Vieta, D PopovicExpert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
History
Journal
European NeuropsychopharmacologyVolume
60Pagination
91-99Location
NetherlandsPublisher DOI
ISSN
0924-977XeISSN
1873-7862Language
EnglishPublication classification
C1 Refereed article in a scholarly journalPublisher
ELSEVIERUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & NeurologyPlaceboDelphiClinical trialTrial-designACTIVE-CONTROL TRIALSPLACEBO-CONTROLLED TRIALSISSUESETHICSSUICIDE420313 Mental health services200409 Mental healthFaculty of HealthSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical Translation
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC